Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127812551 | 12781255 | 1 | I | 20160306 | 20160926 | 20160926 | PER | US-GLENMARK PHARMACEUTICALS INC, USA.-2016GMK022296 | GLENMARK | NANDA A, WASAN A N.. PULMONARY EMBOLISM IN A PATIENT WITH FACTOR V LEIDEN MUTATION, PRESENTING WITH SYMPTOMS OF ASTHMA EXACERBATION.. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. 2016;137 (2 SUPPL.1):AB202 | 52.00 | YR | F | Y | 0.00000 | 20160926 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127812551 | 12781255 | 1 | PS | MONTELUKAST SODIUM. | MONTELUKAST SODIUM | 1 | UNK | U | 90926 | ||||||||||
| 127812551 | 12781255 | 2 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | 220 ?G, TWO PUFFS TWICE DAILY | 0 | 220 | UG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127812551 | 12781255 | 1 | Asthma |
| 127812551 | 12781255 | 2 | Asthma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127812551 | 12781255 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |